Amgen, Inc. is a global biotechnology company that
discovers, develops, manufactures and markets human therapeutics
based on advances in cellular and molecular biology. In July 2002,
the Company completed its acquisition of Immunex Corporation, a
biotechnology company dedicated to developing immune system
science to protect human health. The Company markets human
therapeutic products including Epogen (Epoetin alfa), Aranesp (darbepoetin
alfa), Neupogen (Filgrastim), Neulasta (pegfilgrastim) and Kineret
(anakinra). Amgen acquired the rights to Enbrel (etanercept) as a
result of the Immunex acquisition. Enbrel is marketed with Wyeth
under a co-promotion agreement.
What is the stock
symbol for Amgen? AMGN
Click here for the
current Amgen stock price.
this stock a good buy?
The Rogue Investor ebook is the only
information on investing I've ever found that was useful and understandable. I
enjoyed its format and its brevity. I'm not sure what improvements there would
be to make on the book. It is something everyone should read whether or not
they are interested in serious investing. Thank you very much!
- Kevin Davis
you tired of investing
in the stock market?
can safely earn 18 to 50 percent
per year investing in government-
sponsored tax lien certificates.
I wanted to let you know that I've spent the last several
hours reading [your book] and I'm having a great time with it. It's a
terrific read and you should be complimented with the care and detail
you've put into it.
Thank you very much,